Intelligene Inc.

NT$12.70As of Sun 8 Nov 2026, 12:00 UTC
TPEx:7832Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (12.13%)
Biological Products, Except Diagnostic Substances
Beta (5Y) —
PE TTM —
TSR TTM 2.01%
Mkt cap NT$7.366B
ROIC (11.00%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$16
27.47%
(16.19%)
Hold 7|8|2|11|10
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.15
0.16
0.16
0.17
18.27%
16.19%
10.38%
11.88%
RevenueNT$M
400.0
402.5
401.6
417.8
6.63%
7.47%
4.69%
5.94%
Peers (US$222.5M)
Cap (US$)
PE
187.8M
—
Capital
TTM
5Y
10Y
Leveragex
0.923
1.029
1.080
EBIT/Intx
0.738
1.367
1.336
Own earn%
(0.22)
(54.44)
(72.21)
Sh yield%
35.89
39.32
39.53
Owners
Insiders/Inst%
2.08
89.15
Short interest%
1.05
SBC / revenue%
2.72
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
26–32
$1 testx
—
Incr. ROIC%
1